Sales
Reach potential customers, pilot organizations, adopters, and program buyers.
Research-to-market campaigns
RTM Studio turns research-derived products into clear, pain-point-led solutions for the people and organizations most likely to buy, pilot, fund, or champion them. Then we build the audience and manage the outreach that opens qualified market conversations.
Not another platform
We build and run the work behind relevant partner outreach: the story, target-account strategy, campaign audience, personalized message, response process, and next-cycle learning.
Your team owns the technical story and the relationship. We operate the system that helps the right people hear it.
Partner signal architecture
We start with the external opportunity you need to create, then build the audience, message, and campaign around it.
Reach potential customers, pilot organizations, adopters, and program buyers.
Introduce the opportunity to aligned investors, sponsors, and strategic funders.
Create conversations with partners, integrators, collaborators, and channels.
Put your work in front of media, events, associations, and communities shaping the field.
Reach specialized talent, leaders, advisors, and mission-aligned networks.
The RTM signal system
Define the opportunity, approved story, and conversation your team needs to create.
Build the purpose-specific audience: accounts, funders, partners, media, or talent sources.
Activate a researched, personalized campaign through approved infrastructure.
Route relevant replies, manage campaign signals, and support the next step.
Use what the campaign reveals to sharpen the next audience, message, and opportunity.
What we do
RTM Studio combines the thinking, research, and campaign operations needed to create relevant external momentum.
We translate your capabilities, program, facility, technology, or initiative into a partner-facing story built around what the outside world needs to understand—and why it should care.
We build the organizations and people behind your next objective—researched, qualified, and organized around a credible reason to engage.
We connect your message, audience, outreach, response process, and next steps in one coordinated campaign—not a generic sequence or a handoff of software.
RTM × MedLaunchOS
The RTM MedTech Launchpad connects regulatory-pathway readiness, evidence and claims planning, clinical and commercial stakeholder mapping, and the Campaign Cell needed for a credible U.S. market-entry plan.
Plan a MedTech / 510(k) Diagnostic ↗See the performance engine ↓
Owner-controlled operating foundation
RTM brings the research-to-market operating model. MedLaunchOS supplies the owner-controlled MedTech regulatory-commercialization workflow.
Clarify the device, U.S. entry stage, approved context, target stakeholders, and desired market conversation.
Shape predicate, substantial-equivalence, evidence, documentation, and claims-readiness work around the device and pathway.
Map the clinical, KOL, procurement, distributor, payer, investor, and strategic-partner ecosystem around the approved plan.
Activate an approved-message Campaign Cell for relevant market conversations, reply routing, and next-cycle learning.
Regulatory-to-Market Performance Engine
At launch-relevant checkpoints, the operating plan checks the current message, claims, pathway stage, evidence handoff, and accountable owner. It flags a possible mismatch in plain language for the designated owner to review.
Potential gap detected
Confirm that the current market statement matches the approved pathway stage and claims context.
No local planning response has been selected. No claim is approved and no external action is taken.
The engine records this planning response locally in this browser for the current visitor. In a live engagement, the designated owner’s decision is recorded in the agreed operating record. It does not silently approve regulatory claims or automatically block ordinary approved work.
MedTech scope is diagnostic-dependent. The regulatory pathway, predicate strategy, testing, evidence, submission, clearance, labeling, reimbursement, claims, and commercial activation depend on the device, indication, classification, evidence, and approved market plan. RTM does not promise FDA clearance, an FDA review outcome, a submission timeline, clinical sufficiency, reimbursement, or commercial results.
Campaign Cell Build
For organizations ready to move beyond the Diagnostic, RTM offers a done-for-you, client-owned Campaign Cell Build: the market translation, audience and message system, approved production configuration, reply routing, and operating handoff for one defined market opportunity.
Route A · Managed Campaign Cell
$10,000Activation
RTM designs and operates one 90-day market-learning Cell around an approved objective, ICP, and desired conversation.
Route B · Done-for-you, client-owned Build
$15,000One Cell Build
$7,500 at kickoff · $7,500 at Technical and Launch Readiness acceptance
RTM builds a durable, client-controlled Campaign Cell for a team that wants to operate the approved assets after handoff.
One research-derived offer · one objective · one primary ICP · one priority pain point · one desired conversation · one accountable response owner.
The client controls the agreed Cell assets and client accounts where included, subject to the relevant provider, registrar, mailbox, data-source, and platform terms. RTM does not sell raw lists or transfer third-party licenses.
Scope comparison
Every path begins with the Campaign Diagnostic. Statuses identify the starting scope—not a delivery promise—and final implementation remains governed by the approved plan.
On smaller screens, scroll the comparison sideways to review every tier.
| Build feature | Standard$15,000 | Deep Data$20,000 | High-Volume$35,000 | Enterprise$50,000 |
|---|---|---|---|---|
| Research-to-ICP and pain-point translation | ✓ Included | ✓ Included | ✓ Included | ✓ Included |
| Strategic audience brief and audience/list specification | ✓ Included | ✓ Included | ✓ Included | ✓ Included |
| Message architecture and conversation routing | ✓ Included | ✓ Included | ✓ Included | ✓ Included |
| Standard technical and launch readiness | ✓ Included | ✓ Included | ✓ Included | ✓ Included |
| Client asset ownership register and handoff | ✓ Included | ✓ Included | ✓ Included | ✓ Included |
| 30-day stabilization | ✓ Included | ✓ Included | ✓ Included | ✓ Included |
| Advanced data research and enrichment design | — Not standard | ✓ Included | ✓ Included | ✓ Included |
| Multi-signal targeting and segmentation | — Not standard | ◆ Custom scope | ✓ Included | ✓ Included |
| Complex multi-stakeholder audience modeling | — Not standard | ◆ Custom scope | ✓ Included | ✓ Included |
| Multi-segment campaign architecture | — Not standard | — Not standard | ◆ Custom scope | ✓ Included |
| Expanded capacity and infrastructure planning | — Not standard | — Not standard | ◆ Custom scope | ◆ Custom scope |
| Governance and approval routing | — Not standard | — Not standard | ◆ Custom scope | ✓ Included |
| Enterprise reporting and escalation design | — Not standard | — Not standard | — Not standard | ✓ Included |
| Tailored multi-objective operating handoff | — Not standard | — Not standard | ◆ Custom scope | ✓ Included |
| Optional ongoing Campaign Command | ○ Optional | ○ Optional | ○ Optional | ○ Optional |
Where it remains appropriate to the approved client-controlled plan, Route B may include up to 17 dedicated sending domains and 50 mailboxes. Final technical scope, capacity, timeline, infrastructure, support, and activation remain diagnostic-dependent. RTM does not provide raw lists, platform access, or a guarantee of sending volume, replies, meetings, revenue, or results.
Planning model
Explore a transparent scenario using your own assumptions. This tool models arithmetic from the values you enter; it does not estimate the likelihood of any result.
Planning model only. It does not predict replies, meetings, revenue, funding, partnerships, or other outcomes. Final scope and investment are confirmed through the Campaign Diagnostic.
A Campaign Cell Build is a scoped implementation—not a promise of send volume, replies, meetings, revenue, funding, partnerships, or a result from a named prospect. The exact first-launch payload remains client-approved and separately controlled.
Purpose-built audiences
A generic contact list does not create momentum. The right audience is designed around the action you need someone to take—and the story that gives them a reason to respond.
Build your campaign audience ↗Buyers, pilot organizations, technical evaluators, licensees, adopters, and program buyers.
Investors, corporate venture teams, strategic funders, sponsors, and foundations.
Integrators, collaborators, channels, co-development partners, and ecosystem leaders.
Media, analysts, events, associations, technical communities, and field influencers.
Specialized candidates, advisors, leaders, fellows, and high-signal talent communities.
The difference
A campaign in practice
A university research center may have active projects, distinct expertise, and facilities relevant to a defined sector. Its existing materials explain the work—but do not reliably create new external conversations.
The partner story, approved proof points, and how organizations can engage.
Priority industries, account types, roles, relevance signals, and exclusions.
Personalized outreach, campaign operations, reply routing, and learning.
The result: a repeatable campaign system that gives relevant organizations a reason to understand the center’s work—and gives the center an organized way to act on interest.
The research outreach standard
Research work should not be reduced to generic marketing language. RTM Studio begins with approved claims, relevance-based targeting, and a clear response path—so outreach reflects both the opportunity and standards behind it.
Start with the objective
Tell us what you want to amplify. We will use the information to prepare the right first conversation about fit, audience, and campaign scope.
◎ RTM Studio is a managed service. The operating workflow is supported by specialist lead-research, verification, and campaign tools—not sold as software access or data resale.
Ask AlexRTM Signal Guide
Alex is a guided front door to RTM’s approved site paths. Choose a starting point to see the relevant next step.
Ask Alex
I’ll keep the next step tied to an approved RTM page or the local Operator Console.
Guide mode only. Alex is not an active AI chat or live-voice assistant in this panel. It does not collect or send a message. MedTech questions remain diagnostic-led and do not receive regulatory, clinical, legal, reimbursement, or outcome advice here.